Butyltriphenylphosphonium

Butyltriphenylphosphonium

SCHEMBL584160

CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[F-]

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.61
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
TSHR P16473 1/20 0.47
CYP2C19 P33261 1/20 0.47
CHRNA7 P36544 8/20 0.42
TRAP1 Q12931 2/20 0.41
CNR2 P34972 1/20 0.40
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyltriphenylphosphonium SCHEMBL531998 0.98 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL30358591 0.98 HIF1A (0.64) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL3418099 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL159490 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL1063 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL8535782 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL584744 0.95 HIF1A (0.61) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Fluoride Ion SCHEMBL16752639 0.93 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL2650050 0.93 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR
Butyltriphenylphosphonium SCHEMBL7865507 0.93 HIF1A (0.58) HIF1AALDH1A1CYP1A2CYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304580-B2 Method for producing tris(perfluoroalkanesulfonyl)methide acid salt CENTRAL GLASS COMPANY, LIMITED (JP) 2012-11-06 US claimed
EP-2080753-B1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT CENTRAL GLASS CO LTD (JP) 2012-02-15 EP claimed
US-20100022803-A1 Method for Producing Tris(Perfluoroalkanesulfonyl)Methide Acid Salt CENTRAL GLASS COMPANY, LIMITED (JP) 2010-01-28 US claimed
EP-2080753-A1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT Central Glass Company, Limited (JP) 2009-07-22 EP claimed
CN-108232168-B Modified lithium iron phosphate composite material and preparation method thereof 河北力滔电池材料有限公司 2020-06-09 CN disclosed
US-9221740-B2 Method for producing carbonate compound and method for producing aromatic polycarbonate ASAHI GLASS COMPANY, LIMITED (JP) 2015-12-29 US disclosed
EP-2883861-A1 METHOD FOR PRODUCING CARBONATE COMPOUND AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE Asahi Glass Company, Limited (JP) 2015-06-17 EP disclosed
US-20150152037-A1 METHOD FOR PRODUCING CARBONATE COMPOUND AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE AGC Inc. (JP) 2015-06-04 US disclosed
US-8304580-B2 Method for producing tris(perfluoroalkanesulfonyl)methide acid salt CENTRAL GLASS COMPANY, LIMITED (JP) 2012-11-06 US disclosed
EP-2080753-B1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT CENTRAL GLASS CO LTD (JP) 2012-02-15 EP disclosed
US-20100022803-A1 Method for Producing Tris(Perfluoroalkanesulfonyl)Methide Acid Salt CENTRAL GLASS COMPANY, LIMITED (JP) 2010-01-28 US disclosed
EP-2080753-A1 METHOD FOR PRODUCING TRIS(PERFLUOROALKANESULFONYL)METHIDE ACID SALT Central Glass Company, Limited (JP) 2009-07-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152037-A1 METHOD FOR PRODUCING CARBONATE COMPOUND AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE PKD1, CA2, CA11 HIF1A 1823/4885ALDH1A1 3710/4885CYP1A2 487/4885
US-20100022803-A1 Method for Producing Tris(Perfluoroalkanesulfonyl)Methide Acid Salt PFAS, AFF1, AFF2 HIF1A 3540/4885ALDH1A1 4582/4885CYP1A2 3713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.